Monthly summaries of insider trading activities (stock purchases, sales, and option exercises) reported by insiders of Viking Therapeutics, Inc.
since 2005 are illustrated in Table 1 and Table 2. Table 1 shows the monthly insider trading data of Viking Therapeutics, Inc. since year 2005.
Table 2 shows the detailed insider transactions of Viking Therapeutics, Inc. since 2005.
The reporting company's ticker symbol is VKTX. The reporting company's CIK number is 1607678.
The total value of stock buying since 2005 is $630,580.
The total value of stock sales since 2005 is $199,346.
The total value of stock option exercises since 2005 is $0.
|Trading Period||Insider Buying||Insider Sales||Option Exercises|
|Trade Date||Insider Name||Trade Type||Shares||Price ($)||Value ($)|
|2018-05-31||Morneau Michael (VP, Finance and Administration)||Sale||21,551||9.25||199,346|
|2018-05-31||Singleton J Matthew (Director)||Buy||9,500||9.82||93,261|
|2018-05-29||Macartney Lawson (Director)||Buy||47,965||5.22||250,329|
|2018-05-29||Webster Stephen W (Director)||Buy||8,000||5.21||41,712|
|2018-05-29||Rowland Charles A Jr (Director)||Buy||30,000||5.16||154,800|
|2016-11-15||Foehr Matthew W (Director)||Buy||13,000||1.21||15,678|
|2016-04-13||Foehr Matthew W (Director)||Buy||20,000||1.24||24,800|
|2015-05-04||Foehr Matthew W (Director)||Buy||6,250||8.00||50,000|
Insider trading activities including stock purchases, stock sales, and option exercises of VKTX listed in the above tables cannot be completely guaranteed as to their accuracy. For more insider trading information of Viking Therapeutics, Inc. (symbol VKTX, CIK number 1607678) see the Securities and Exchange Commission (SEC) website.